Being newly diagnosed with ABPA (Allergic Bronchopulmonary Aspergillosis) can feel overwhelming, especially when faced with complicated information online. You may hear about disease stages, possible complications, and unfamiliar terms. This guide is here to reassure you: ABPA is a manageable condition, and with the right treatment and monitoring, many people live full and active lives.
What Is ABPA?
ABPA is an allergic reaction in your lungs caused by a fungus called Aspergillus fumigatus. It’s more likely to affect people with existing lung conditions such as:
- Asthma
- Bronchiectasis
- Cystic fibrosis (in some cases)
The immune system overreacts to the presence of Aspergillus, leading to inflammation, mucus buildup, and sometimes long-term lung changes.
Can ABPA Become CPA?
Some people worry that ABPA might turn into CPA (Chronic Pulmonary Aspergillosis), a separate fungal lung infection.
- This only happens in a small number of people, usually those with severe lung damage or cavities.
- If ABPA is well-managed early, the chances of developing CPA are very low.
- Your care team can monitor for this with scans and blood tests.
The 5 Stages of ABPA: What Do They Mean?
The stages of ABPA are used by doctors to describe how the disease behaves, not to predict life expectancy.
| Stage | What It Means |
|---|---|
| 1 | Acute: Flare-up with symptoms and high IgE |
| 2 | Response to treatment |
| 3 | Remission: Symptoms and inflammation settle |
| 4 | Relapse: New flare-up after remission |
| 5 | Fibrotic: Long-term scarring in the lungs |
Even Stage 5 is not a death sentence. Some people live in this stage for many years with stable symptoms. It just means that some lung changes have become permanent.
Key Goals of ABPA Management
With the right care, people with ABPA can:
- Prevent long-term lung damage
- Reduce flare-ups
- Stay active and independent
Your treatment may include:
- Corticosteroids to reduce inflammation
- Antifungal medications (like itraconazole) to reduce fungal burden
- Biologics (like omalizumab or dupilumab) in some cases
- Mucus clearance physiotherapy
- Environmental control to reduce exposure to mould and dust
What You Can Do to Stay Well
- Stick to your treatment plan and attend regular check-ups
- Monitor symptoms like coughing, mucus, breathlessness or chest pain
- Practice good airway clearance techniques
- Avoid triggers: e.g., mould, compost, damp areas
- Seek support: Patient groups, nurses, respiratory therapists can help
Final Reassurance
Being diagnosed in February means you are still early in your journey, and that’s a good thing. You have time to learn, adapt, and manage your condition.
ABPA does not mean you are dying — it means you are living with a chronic condition that can be controlled with the right tools and knowledge.
You are not alone, and with support, you can live well with ABPA.
Share this post
Latest News posts
⭐ Recent Aspergillosis Research & Guideline Updates (Week 47)
November 17, 2025
Why Join the Aspergillosis Patient Advisory Group (PAG)?
November 17, 2025
FINDING COMFORT & PURPOSE ON LOW-ENERGY DAYS
November 17, 2025
Inhaled Steroids and ABPA: Do They Help or Should They Be Avoided?
November 17, 2025
ABPA or Bronchiectasis? A Detailed Guide to Understanding Flare-Ups
November 17, 2025
News archive
- ABPA
- Air Quality
- Airway Clearance, Diagnosis & Physiotherapy
- Antifungals
- Aspergilloma
- Aspergillus Bronchitis
- Biologics
- Blood Tests
- CPA
- Carers & Family
- Communities
- Complementary & Supplements
- Complications
- Conditions
- Diagnostics
- Environment
- Events & Recordings
- GP Guidance
- General interest
- Housing & Damp
- Imaging
- Immune System
- Lifestyle & Coping
- Living with Aspergillosis
- Mental Health
- Monitoring
- Monitoring & Safety
- NAC & Guidance
- NAC Announcements
- Other
- Other Forms Aspergillosis
- Patient Research
- Pets & Animals
- Professional Guidance
- Recordings
- Research
- Research Summaries
- SAFS / Severe Asthma
- Side Effects
- Steroids
- Symptoms
- Travel and Insurance
- Treatment
- Vaccines
- Weekly Updates
